[{"address1": "1800 Owens Street", "address2": "Suite 900", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 906 4324", "website": "https://www.vir.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.", "fullTimeEmployees": 587, "companyOfficers": [{"maxAge": 1, "name": "Dr. Marianne  De Backer M.B.A., M.Sc., Ph.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 4467539, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ann M. Hanly Ph.D.", "age": 54, "title": "Executive VP & Chief Technology Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 896072, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeff  Calcagno M.D.", "age": 63, "title": "Executive VP & Chief Business Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 860494, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Klaus  Frueh Ph.D.", "age": 64, "title": "Co-Founder & Scientific Advisor", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 177661, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 77, "title": "Co-Founder & Scientific Advisor", "yearBorn": 1947, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Louis J. Picker M.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  O'Byrne", "age": 56, "title": "Executive VP & CFO", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brent  Sabatini", "age": 50, "title": "Senior VP, Principal Accounting Officer & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jennifer Eileen Towne Ph.D.", "title": "Executive VP & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heather Rowe Armstrong", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.05, "open": 10.16, "dayLow": 10.02, "dayHigh": 10.28, "regularMarketPreviousClose": 10.05, "regularMarketOpen": 10.16, "regularMarketDayLow": 10.02, "regularMarketDayHigh": 10.28, "beta": 0.457, "forwardPE": -2.745984, "volume": 1048359, "regularMarketVolume": 1048359, "averageVolume": 2164573, "averageVolume10days": 6077810, "averageDailyVolume10Day": 6077810, "bid": 7.35, "ask": 12.94, "bidSize": 100, "askSize": 100, "marketCap": 1392349184, "fiftyTwoWeekLow": 6.56, "fiftyTwoWeekHigh": 14.45, "priceToSalesTrailing12Months": 17.71031, "fiftyDayAverage": 8.3752, "twoHundredDayAverage": 8.758075, "currency": "USD", "enterpriseValue": 590689408, "floatShares": 92514868, "sharesOutstanding": 137720000, "sharesShort": 6553893, "sharesShortPriorMonth": 6163469, "sharesShortPreviousMonthDate": 1732838400, "dateShortInterest": 1735603200, "sharesPercentSharesOut": 0.0476, "heldPercentInsiders": 0.11903, "heldPercentInstitutions": 0.74082, "shortRatio": 4.51, "shortPercentOfFloat": 0.077199996, "impliedSharesOutstanding": 158404000, "bookValue": 9.076, "priceToBook": 1.1139268, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -533344000, "trailingEps": -3.93, "forwardEps": -3.74, "enterpriseToRevenue": 7.513, "enterpriseToEbitda": -1.106, "52WeekChange": 0.053125024, "SandP52WeekChange": 0.23631513, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "VIR", "underlyingSymbol": "VIR", "shortName": "Vir Biotechnology, Inc.", "longName": "Vir Biotechnology, Inc.", "firstTradeDateEpochUtc": 1570800600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ebff203c-69dd-36be-a47c-35beb1571fec", "messageBoardId": "finmb_419881198", "gmtOffSetMilliseconds": -18000000, "currentPrice": 10.11, "targetHighPrice": 110.0, "targetLowPrice": 14.0, "targetMeanPrice": 31.375, "targetMedianPrice": 20.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 914473984, "totalCashPerShare": 6.64, "ebitda": -533936992, "totalDebt": 112813000, "quickRatio": 7.851, "currentRatio": 8.938, "totalRevenue": 78618000, "debtToEquity": 9.092, "revenuePerShare": 0.579, "returnOnAssets": -0.19406, "returnOnEquity": -0.36583, "grossProfits": -416932992, "freeCashflow": -356994624, "operatingCashflow": -466644000, "revenueGrowth": -0.098, "operatingMargins": -91.84538, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]